Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
6 clinical trials · Condition
◉ Watch Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN) (NCT04882735) | Eidos Therapeutics, a BridgeBio company | 2021-09-08 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) (NCT04601051) | Intellia Therapeutics | 2020-11-05 |
| Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy (NCT04418024) | Eidos Therapeutics, a BridgeBio company | 2020-10-21 |
| Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) (NCT02713880) | CENTOGENE GmbH Rostock | 2018-08-20 |
| TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (NCT03237494) | CENTOGENE GmbH Rostock | 2017-07-20 |
Track Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy automatically
Every clearance here is in the API, with alerts when new ones post.